Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded site revision label v3.4.2 and removed the lapse-in-government-funding notice (and the previous v3.4.1 revision).SummaryDifference0.4%

- Check21 days agoChange DetectedNew site-wide notice explains potential processing delays due to a government funding lapse and updates the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now displays a glossary and adds QC/FEAR Act metadata (Last Update Submitted that Met QC Criteria and No FEAR Act Data), with the revision updated to v3.4.0 and the prior QC label and older revision removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe update shows a revision from v3.3.3 to v3.3.4 with no visible edits to the study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new Locations section listing California, Kansas, Nevada, North Carolina, and Virginia, while removing the prior state-specific location blocks, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check92 days agoChange DetectedThe Publications section now clarifies that items are automatically filled from PubMed and may not be about the study, and the revision label updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.